VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,206,000 | +52.7% | 180,986 | +4.6% | 0.00% | – |
Q1 2018 | $2,754,000 | -13.4% | 173,004 | +13.0% | 0.00% | – |
Q4 2017 | $3,180,000 | +44.8% | 153,117 | -0.1% | 0.00% | – |
Q3 2017 | $2,196,000 | +47.9% | 153,307 | +78.7% | 0.00% | – |
Q2 2017 | $1,485,000 | +42.1% | 85,799 | -9.4% | 0.00% | – |
Q1 2017 | $1,045,000 | -40.9% | 94,736 | -22.2% | 0.00% | – |
Q4 2016 | $1,767,000 | -50.4% | 121,700 | -16.2% | 0.00% | – |
Q3 2016 | $3,566,000 | +9.6% | 145,265 | -10.1% | 0.00% | – |
Q2 2016 | $3,253,000 | -2.4% | 161,545 | +27.5% | 0.00% | – |
Q1 2016 | $3,332,000 | -69.0% | 126,698 | +19.9% | 0.00% | -100.0% |
Q4 2015 | $10,745,000 | -3.5% | 105,698 | +69.3% | 0.00% | 0.0% |
Q3 2015 | $11,137,000 | -34.7% | 62,429 | -18.7% | 0.00% | -50.0% |
Q2 2015 | $17,059,000 | -6.9% | 76,792 | -16.7% | 0.00% | 0.0% |
Q1 2015 | $18,318,000 | +37.5% | 92,227 | -1.0% | 0.00% | +100.0% |
Q4 2014 | $13,325,000 | -23.9% | 93,118 | -30.2% | 0.00% | -50.0% |
Q3 2014 | $17,508,000 | +113.8% | 133,445 | +105.6% | 0.00% | +100.0% |
Q2 2014 | $8,189,000 | -57.7% | 64,917 | -55.8% | 0.00% | -50.0% |
Q1 2014 | $19,364,000 | +220.9% | 146,876 | +104.9% | 0.00% | – |
Q4 2013 | $6,034,000 | -89.5% | 71,684 | -87.0% | 0.00% | -100.0% |
Q3 2013 | $57,726,000 | +2219.2% | 553,310 | +1813.9% | 0.01% | – |
Q2 2013 | $2,489,000 | – | 28,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |